Company Analysis Terumo Corporation
1. Summary
Advantages
- Price (18.7 $) is less than fair price (42.29 $)
- Dividends (2.78%) are higher than the sector average (2.17%).
- The stock's return over the last year (10.65%) is higher than the sector average (-9.33%).
- Current debt level 12.66% is below 100% and has decreased over 5 years from 24.58%.
Disadvantages
- The company's current efficiency (ROE=8.73%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
Terumo Corporation | Healthcare | Index | |
---|---|---|---|
7 days | 0.4% | -12.9% | 1.6% |
90 days | 6.6% | -14.6% | 7.1% |
1 year | 10.7% | -9.3% | 11.9% |
TRUMY vs Sector: Terumo Corporation has outperformed the "Healthcare" sector by 19.98% over the past year.
TRUMY vs Market: Terumo Corporation has underperformed the market marginally by -1.26% over the past year.
Stable price: TRUMY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TRUMY with weekly volatility of 0.2048% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (18.7 $) is lower than the fair price (42.29 $).
Price significantly below the fair price: The current price (18.7 $) is 126.1% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (38.96) is higher than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (38.96) is lower than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.12) is lower than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (3.12) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.5) is higher than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (4.5) is higher than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (18.93) is higher than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (18.93) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.97% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.97%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (8.73%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (8.73%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (6.2%) is higher than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (6.2%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (9.03%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (9.03%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.78% is higher than the average for the sector '2.17%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.78% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 2.78% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (30.09%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription